Tag: Semaglutide
Browse all articles tagged with “Semaglutide”.
5 articles
Semaglutide and the GLP-1 Revolution: What Researchers Need to Know
A comprehensive research overview of semaglutide, the GLP-1 receptor agonist that has reshaped metabolic health research with over 169 PubMed studies, $29.3B in revenue, and expanding clinical applications from weight management to cardiovascular outcomes.
Semaglutide vs Tirzepatide: GLP-1 Agonist Comparison
A comprehensive comparison of semaglutide and tirzepatide, the two leading GLP-1 receptor agonists. Examine clinical trial data, mechanisms, efficacy, side effects, cost, and FDA approval status.
The Complete Guide to GLP-1 Receptor Agonists: From Semaglutide to Retatrutide
An in-depth comparison of every major GLP-1 receptor agonist in research and clinical development, including semaglutide, tirzepatide, retatrutide, liraglutide, cagrilintide, survodutide, and mazdutide. Mechanism differences, efficacy data, and market positions.
What Is Semaglutide? A Research Overview
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become one of the most studied compounds for weight management and metabolic health.
Cagrilintide: The Long-Acting Amylin Analog Behind CagriSema
A research overview of cagrilintide, Novo Nordisk's investigational long-acting amylin analog designed for weekly dosing and studied in combination with semaglutide as CagriSema for enhanced weight management.
For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.